Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.62M | -8.29M | -7.87M | -7.83M | -8.07M |
| Total Depreciation and Amortization | 4.40K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.36M | 804.80K | 580.30K | 453.50K | 622.70K |
| Change in Net Operating Assets | 215.30K | 510.90K | -727.90K | -648.60K | -435.30K |
| Cash from Operations | -8.04M | -6.98M | -8.02M | -8.02M | -7.88M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.81M | 4.74M | 3.68M | 6.09M | 2.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.81M | 4.74M | 3.68M | 6.09M | 2.41M |
| Foreign Exchange rate Adjustments | -13.00K | -18.30K | 533.80K | 45.40K | -6.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.75M | -2.25M | -3.81M | -1.89M | -5.48M |